97 related articles for article (PubMed ID: 27461521)
21. ERK1/2 signalling pathway is involved in CD147-mediated gastric cancer cell line SGC7901 proliferation and invasion.
Chen L; Pan Y; Gu L; Nie Z; He B; Song G; Li R; Xu Y; Gao T; Wang S
Exp Biol Med (Maywood); 2013 Aug; 238(8):903-12. PubMed ID: 23828593
[TBL] [Abstract][Full Text] [Related]
22. Neem leaf glycoprotein restores the impaired chemotactic activity of peripheral blood mononuclear cells from head and neck squamous cell carcinoma patients by maintaining CXCR3/CXCL10 balance.
Chakraborty K; Bose A; Pal S; Sarkar K; Goswami S; Ghosh D; Laskar S; Chattopadhyay U; Baral R
Int Immunopharmacol; 2008 Feb; 8(2):330-40. PubMed ID: 18182249
[TBL] [Abstract][Full Text] [Related]
23. CXCL10 promotes invasion-related properties in human colorectal carcinoma cells.
Zipin-Roitman A; Meshel T; Sagi-Assif O; Shalmon B; Avivi C; Pfeffer RM; Witz IP; Ben-Baruch A
Cancer Res; 2007 Apr; 67(7):3396-405. PubMed ID: 17409450
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of HMGB1 inhibits growth and invasion of gastric cancer cells through the NF-κB pathway in vitro and in vivo.
Zhang J; Kou YB; Zhu JS; Chen WX; Li S
Int J Oncol; 2014 Apr; 44(4):1268-76. PubMed ID: 24481712
[TBL] [Abstract][Full Text] [Related]
25. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines.
Weng J; Wang C; Wang Y; Tang H; Liang J; Liu X; Huang H; Hou J
Oral Oncol; 2014 Oct; 50(10):983-90. PubMed ID: 25096824
[TBL] [Abstract][Full Text] [Related]
26. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
27. Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies.
Cannon A; Thompson CM; Bhatia R; Kandy RRK; Solheim JC; Batra SK; Kumar S
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188628. PubMed ID: 34560199
[TBL] [Abstract][Full Text] [Related]
28. Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3.
Struyf S; Salogni L; Burdick MD; Vandercappellen J; Gouwy M; Noppen S; Proost P; Opdenakker G; Parmentier M; Gerard C; Sozzani S; Strieter RM; Van Damme J
Blood; 2011 Jan; 117(2):480-8. PubMed ID: 20980681
[TBL] [Abstract][Full Text] [Related]
29. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
[TBL] [Abstract][Full Text] [Related]
30. Interference of lysine-specific demethylase 1 inhibits cellular invasion and proliferation in vivo in gastric cancer MKN-28 cells.
Li Y; Tian X; Sui CG; Jiang YH; Liu YP; Meng FD
Biomed Pharmacother; 2016 Aug; 82():498-508. PubMed ID: 27470390
[TBL] [Abstract][Full Text] [Related]
31. CXCR3 as a molecular target in breast cancer metastasis: inhibition of tumor cell migration and promotion of host anti-tumor immunity.
Zhu G; Yan HH; Pang Y; Jian J; Achyut BR; Liang X; Weiss JM; Wiltrout RH; Hollander MC; Yang L
Oncotarget; 2015 Dec; 6(41):43408-19. PubMed ID: 26485767
[TBL] [Abstract][Full Text] [Related]
32. DJ-1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
Zhu ZM; Li ZR; Huang Y; Yu HH; Huang XS; Yan YF; Shao JH; Chen HP
Oncol Rep; 2014 Mar; 31(3):1489-97. PubMed ID: 24398929
[TBL] [Abstract][Full Text] [Related]
33. SALL4, a novel marker for human gastric carcinogenesis and metastasis.
Zhang L; Xu Z; Xu X; Zhang B; Wu H; Wang M; Zhang X; Yang T; Cai J; Yan Y; Mao F; Zhu W; Shao Q; Qian H; Xu W
Oncogene; 2014 Nov; 33(48):5491-500. PubMed ID: 24276240
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling.
Zheng H; Zhang F; Lin X; Huang C; Zhang Y; Li Y; Lin J; Chen W; Lin X
Oncotarget; 2016 Jan; 7(4):4647-63. PubMed ID: 26684358
[TBL] [Abstract][Full Text] [Related]
35. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
Kim SM; Kwon CH; Shin N; Park DY; Moon HJ; Kim GH; Jeon TY
Int J Cancer; 2014 Jan; 134(1):114-24. PubMed ID: 23801416
[TBL] [Abstract][Full Text] [Related]
36. CXCR3 ligands in disease and therapy.
Van Raemdonck K; Van den Steen PE; Liekens S; Van Damme J; Struyf S
Cytokine Growth Factor Rev; 2015 Jun; 26(3):311-27. PubMed ID: 25498524
[TBL] [Abstract][Full Text] [Related]
37. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
39. Association of CXCR1 and 2 expressions with gastric cancer metastasis in ex vivo and tumor cell invasion in vitro.
Li Z; Wang Y; Dong S; Ge C; Xiao Y; Li R; Ma X; Xue Y; Zhang Q; Lv J; Tan Q; Zhu Z; Song X; Tan J
Cytokine; 2014 Sep; 69(1):6-13. PubMed ID: 25022956
[TBL] [Abstract][Full Text] [Related]
40. The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer.
Kuo PT; Zeng Z; Salim N; Mattarollo S; Wells JW; Leggatt GR
Front Med (Lausanne); 2018; 5():271. PubMed ID: 30320116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
